Appearance of multidrug resistance (MDR) as an early predictor of relapse in imatinib treated chronic myeloid leukaemia patients

被引:0
|
作者
Rideg, O
Teibert, A
Magyarlaki, T
Tökes-Füzesi, M
Miseta, A
Schmelczer, M
Kovács, GL
机构
[1] Univ Pecs, Inst Lab Med, H-7624 Pecs, Hungary
[2] Univ Pecs, Fac Med, Dept Internal Med 2, H-7624 Pecs, Hungary
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:S285 / S285
页数:1
相关论文
共 50 条
  • [1] Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib
    Breccia, M
    Carmosino, I
    Russo, E
    Morano, SG
    Latagliata, R
    Alimena, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (02) : 121 - 123
  • [2] MULTIDRUG RESISTANCE GENE HAPLOTYPE MAY BE A PREDICTOR OF UPFRONT RESISTANCE TO IMATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS
    Soverini, S.
    Turrini, E.
    Gnani, A.
    Colarossi, S.
    Perini, G.
    Iacobucci, I.
    Hrelia, P.
    Forti, Cantelli G.
    Saglio, G.
    Pane, F.
    Baccarani, M.
    Kalebic, T.
    Martinelli, G.
    Angelini, S.
    HAEMATOLOGICA, 2008, 93 : S68 - S68
  • [3] Managing imatinib resistance in chronic myeloid leukaemia
    Osborn, Michael
    Hughes, Timothy
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (02) : 97 - 103
  • [4] Resistance to imatinib mesylate in chronic myeloid leukaemia
    Melo, Junia V.
    Chuah, Charles
    CANCER LETTERS, 2007, 249 (02) : 121 - 132
  • [5] PARTICIPATION IN CHRONIC MYELOID LEUKEMIA (CML) IN APPEARANCE AND IMATINIB RESISTANCE OF MULTI-DRUG RESISTANCE(MDR)
    Nakagawa, Yasunori
    Kurata, Morito
    Suzuki, Kenshi
    Kitagawa, Masanobu
    ANNALS OF ONCOLOGY, 2010, 21 : 16 - 17
  • [6] Multidrug resistance gene (MDR1) polymorphisms may serve as predictors of resistance to imatinib in chronic phase chronic myeloid leukemia patients
    Soverini, Simona
    Angelini, Sabrina
    Turrini, Eleonora
    Gnani, Alessandra
    Colarossi, Sabrina
    Perini, Giovanni
    Iacobucci, Ilaria
    Hrelia, Patrizia
    Forti, Giorgio Cantelli
    Cilloni, Damela
    Saglio, Giuseppe
    Pane, Fabrizio
    Baccarani, Michele
    Kalebic, Thea
    Martinelli, Giovanni
    BLOOD, 2007, 110 (11) : 578A - 578A
  • [7] A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
    Estabragh, Zahra Raisi
    Knight, Katy
    Watmough, Sarah J.
    Lane, Steven
    Vinjamuri, Sobhan
    Hart, George
    Clark, Richard E.
    LEUKEMIA RESEARCH, 2011, 35 (01) : 49 - 51
  • [8] Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia
    Ni, Ling-Na
    Li, Jian-Yong
    Miao, Kou-Rong
    Qiao, Chun
    Zhang, Su-Jiang
    Qiu, Hai-Rong
    Qian, Si-Xuan
    MEDICAL ONCOLOGY, 2011, 28 (01) : 265 - 269
  • [9] Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline
    Crugnola, Monica
    Castagnetti, Fausto
    Breccia, Massimo
    Ferrero, Dario
    Trawinska, Malgorzata Monika
    Abruzzese, Elisabetta
    Annunziata, Mario
    Stagno, Fabio
    Tiribelli, Mario
    Binotto, Gianni
    Bonifacio, Massimiliano
    Fava, Carmen
    Iurlo, Alessandra
    Bucelli, Cristina
    Mansueto, Giovanna
    Gozzini, Antonella
    Falzetti, Franca
    Montefusco, Enrico
    Crisa, Elena
    Gugliotta, Gabriele
    Russo, Sabina
    Cedrone, Michele
    RussoRossi, Antonella
    Pregno, Patrizia
    Isidori, Alessandro
    Mauro, Endri
    Atelda, Romano
    Giglio, Gianfranco
    Celesti, Francesca
    Sora, Federica
    Storti, Sergio
    D'Addosio, Adam
    Galimberti, Sara
    Orlandi, Ester
    Calistri, Elisabetta
    Bocchia, Monica
    Cavazzini, Francesco
    Cambrin, Giovanna Rege
    Orofino, Nicola
    Luciano, Luigiana
    Sgherza, Nicola
    Rosti, Gianantonio
    Latagliata, Roberto
    Capodanno, Isabella
    ANNALS OF HEMATOLOGY, 2019, 98 (10) : 2329 - 2338
  • [10] Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia
    Ling-Na Ni
    Jian-Yong Li
    Kou-Rong Miao
    Chun Qiao
    Su-Jiang Zhang
    Hai-Rong Qiu
    Si-Xuan Qian
    Medical Oncology, 2011, 28 : 265 - 269